Literature DB >> 264472

Properties of the K562 cell line derived from a patient with chronic myeloid leukemia.

B B Lozzio, C B Lozzio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 264472     DOI： 10.1002/ijc.2910190119

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  25 in total

1.  A Burden of Rare Variants Associated with Extremes of Gene Expression in Human Peripheral Blood.

Authors:  Jing Zhao; Idowu Akinsanmi; Dalia Arafat; T J Cradick; Ciaran M Lee; Samridhi Banskota; Urko M Marigorta; Gang Bao; Greg Gibson
Journal:  Am J Hum Genet       Date:  2016-02-04       Impact factor: 11.025

Review 2.  Novel eicosanoid pathways: the discovery of prostacyclin/6-keto prostaglandin F1alpha and the hepoxilins.

Authors:  Cecil R Pace-Asciak
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

3.  Chronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling.

Authors:  Heather A Himburg; Martina Roos; Tiancheng Fang; Yurun Zhang; Christina M Termini; Lauren Schlussel; Mindy Kim; Amara Pang; Jenny Kan; Liman Zhao; Hyung Suh; Joshua P Sasine; Gopal Sapparapu; Peter M Bowers; Gary Schiller; John P Chute
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

4.  Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression.

Authors:  Lucia Poncette; Xiaojing Chen; Felix Km Lorenz; Thomas Blankenstein
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

5.  Salarin C, a member of the salarin superfamily of marine compounds, is a potent inducer of apoptosis.

Authors:  Nathalie Ben-Califa; Ashgan Bishara; Yoel Kashman; Drorit Neumann
Journal:  Invest New Drugs       Date:  2010-08-24       Impact factor: 3.850

6.  Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs.

Authors:  Chiara Chiozzini; Eleonora Olivetta; Massimo Sanchez; Claudia Arenaccio; Flavia Ferrantelli; Patrizia Leone; Maurizio Federico
Journal:  J Mol Med (Berl)       Date:  2019-06-03       Impact factor: 4.599

7.  The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine.

Authors:  Elisabeth J Walsby; Steven J Coles; Steven Knapper; Alan K Burnett
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

Review 8.  Human cell-based artificial antigen-presenting cells for cancer immunotherapy.

Authors:  Marcus O Butler; Naoto Hirano
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.

Authors:  Ilaria Lampronti; Nicoletta Bianchi; Cristina Zuccato; Francesco Dall'Acqua; Daniela Vedaldi; Giampietro Viola; Rocco Potenza; Francesco Chiavilli; Giulia Breveglieri; Monica Borgatti; Alessia Finotti; Giordana Feriotto; Francesca Salvatori; Roberto Gambari
Journal:  Int J Hematol       Date:  2009-09-25       Impact factor: 2.490

10.  Genomic approaches uncover increasing complexities in the regulatory landscape at the human SCL (TAL1) locus.

Authors:  Pawandeep Dhami; Alexander W Bruce; Johanna H Jim; Shane C Dillon; Amanda Hall; Jonathan L Cooper; Nicolas Bonhoure; Kelly Chiang; Peter D Ellis; Cordelia Langford; Robert M Andrews; David Vetrie
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.